Astrana Health Statistics Share Statistics Astrana Health has 49.93M
shares outstanding. The number of shares has increased by 1.73%
in one year.
Shares Outstanding 49.93M Shares Change (YoY) 1.73% Shares Change (QoQ) -0.38% Owned by Institutions (%) n/a Shares Floating 37.13M Failed to Deliver (FTD) Shares 616 FTD / Avg. Volume 0.19%
Short Selling Information The latest short interest is 1.53M, so 3.32% of the outstanding
shares have been sold short.
Short Interest 1.53M Short % of Shares Out 3.32% Short % of Float 5.92% Short Ratio (days to cover) 6.01
Valuation Ratios The PE ratio is 34.85 and the forward
PE ratio is 11.99.
Astrana Health's PEG ratio is
-1.13.
PE Ratio 34.85 Forward PE 11.99 PS Ratio 0.74 Forward PS 0.4 PB Ratio 2.11 P/FCF Ratio 34.04 PEG Ratio -1.13
Financial Ratio History Enterprise Valuation Astrana Health has an Enterprise Value (EV) of 1.69B.
EV / Sales 0.83 EV / EBITDA 11.89 EV / EBIT 32.32 EV / FCF 38.19
Financial Position The company has a current ratio of 2.87,
with a Debt / Equity ratio of 0.66.
Current Ratio 2.87 Quick Ratio 2.87 Debt / Equity 0.66 Debt / EBITDA 3.33 Debt / FCF 10.68 Interest Coverage 2.7
Financial Efficiency Return on Equity is 6.05% and Return on Invested Capital is 4.81%.
Return on Equity 6.05% Return on Assets 3.18% Return on Invested Capital 4.81% Revenue Per Employee $1.07M Profits Per Employee $22.71K Employee Count 1,900 Asset Turnover 1.5 Inventory Turnover n/a
Taxes Income Tax 30.89M Effective Tax Rate 38.22%
Stock Price Statistics The stock price has increased by -38.62% in the
last 52 weeks. The beta is 0.86, so Astrana Health's
price volatility has been higher than the market average.
Beta 0.86 52-Week Price Change -38.62% 50-Day Moving Average 24.44 200-Day Moving Average 33.12 Relative Strength Index (RSI) 65.59 Average Volume (20 Days) 331,148
Income Statement In the last 12 months, Astrana Health had revenue of 2.03B
and earned 43.15M
in profits. Earnings per share was 0.9.
Revenue 2.03B Gross Profit 271.39M Operating Income 89.35M Net Income 43.15M EBITDA 141.84M EBIT 113.92M Earnings Per Share (EPS) 0.9
Full Income Statement Balance Sheet The company has 288.45M in cash and 471.84M in
debt, giving a net cash position of -183.38M.
Cash & Cash Equivalents 288.45M Total Debt 471.84M Net Cash -183.38M Retained Earnings 286.28M Total Assets 1.33B Working Capital 252M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 52.2M
and capital expenditures -8.03M, giving a free cash flow of 44.17M.
Operating Cash Flow 52.2M Capital Expenditures -8.03M Free Cash Flow 44.17M FCF Per Share 0.93
Full Cash Flow Statement Margins Gross margin is 13.34%, with operating and profit margins of 4.39% and 2.12%.
Gross Margin 13.34% Operating Margin 4.39% Pretax Margin 3.97% Profit Margin 2.12% EBITDA Margin 6.97% EBIT Margin 4.39% FCF Margin 2.17%
Dividends & Yields ASTH does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 2.87% FCF Yield 2.94%
Dividend Details Analyst Forecast The average price target for ASTH is $50,
which is 74.3% higher than the current price. The consensus rating is "Buy".
Price Target $50 Price Target Difference 74.3% Analyst Consensus Buy Analyst Count 8
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 17.44 Graham Upside -39.21%
Stock Splits The last stock split was on Apr 27, 2015. It was a
backward
split with a ratio of 1:10.
Last Split Date Apr 27, 2015 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 3.51 Piotroski F-Score 6
